Braskem S.A. American Depositary Shares (Each representing Two Class A Preferred Shares)

The performance of the U.S. corporate bond market in the first quarter of the year was generally flat, though there were notable distinctions between the high-grade and high-yield sectors. Bonds issued by companies with higher credit ratings (BBB and above) experienced a slight downward trajectory, as showed by the iShares iBoxx $ Investment Grade Corporate Bond ETF (NYSE:LQD). Conversely, lower-rated companies boasting higher yields showed modestly positive performance, as indicated by the iShares iBoxx $ High Yield Corporate Bond ETF (NYSE:HYG). Also Read: Top 10 US High-Yield Corporate Bonds With Returns Over 20% In April 2024 Below is a list of U.S. corporate bonds that have exhibited the strongest performance in the last three months. 10) Macy’s Retail Holdings LLC 4.3% 12/43 Issuer: Macy’s Inc. (NYSE:M) ISIN: US55616XAJ63 Last price: $82.08 Yield to maturity (%): 5.9712 Maturity: 15/02/2043 Minimum investment amount: $2,000 3-month performance: 15.83% 9) Ally Financial Inc. 4.7% Issuer: Ally Financial Inc. (NYSE:ALLY) ISIN: US02005NBN93 Last price: $78.174 Type: subordinated Minimum investment amount: $1,000 3-month performance: 16.91% 8) Lincoln National Corp. 7.938% 06/66 Issuer: Lincoln National Corp. ...Full story available on Benzinga.com

Related tickers: HYG, LQD, BAK, LNC, M, MDC, ALLY, CVNA, BYND, LUMN.

U.S. stocks were mixed, with the Dow Jones index gaining around 0.1% on Wednesday. Shares of Sportradar Group AG (NASDAQ: SRAD) rose sharply during Wednesday’s session after the company reported better-than-expected fourth-quarter results and authorized a $200 million share repurchase program. Sportradar posted quarterly earnings of 8 cents per share, beating market estimates of 4 cents per share. The company’s quarterly sales came in at $271.88 million, beating market expectations of $271.46 million, according to data from Benzinga Pro. Sportradar Group shares jumped 10.7% to $11.17 on Wednesday. Here are some other big stocks recording gains in today’s session. Annovis Bio, Inc. (NASDAQ: ANVS) shares surged 25.6% to $11.21 after the company announced the completion of data cleaning for its Phase 2/3 study of Buntanetap in patients with mild to moderate Alzheimer's disease, with Topline efficacy data expected in April. Taysha ...

Related tickers: IBRX, SRAD, LVWR, DWAC, BAK, WULF, CMG, DRCT, PAY, PGY, SPR, MODG, KC, SKIN, ANVS, MARA, LIVN, CLSK, CVNA, ALIT, TSHA.